cetraxate has been researched along with Infections, Helicobacter in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " pylori) infection is known to affect the gastric microcirculation, and cetraxate is reported to accelerate gastric ulcer healing, possibly by augmenting gastric mucosal blood flow (MBF)." | 5.09 | Influence of Helicobacter pylori infection and cetraxate on gastric mucosal blood flow during healing of endoscopic mucosal resection-induced ulcers. ( Adachi, K; Fujishiro, H; Ishihara, S; Kawamura, A; Kazumori, H; Kinoshita, Y; Moriyama, N; Okuyama, T; Sato, H; Suetsugu, H; Watanabe, M, 2001) |
| "Cetraxate is an anti-ulcer drug that increases gastric mucosal blood flow." | 2.69 | Cetraxate, a mucosal protective agent, combined with omeprazole, amoxycillin, and clarithromycin increases the eradication rate of helicobacter pylori in smokers. ( Haruma, K; Hattori, N; Kajiyama, G; Kamada, T; Kawamura, Y; Kitadai, Y; Mihara, M; Miyoshi, E; Mukai, T; Sumii, K; Tahara, K; Yoshihara, M, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, CJ | 1 |
| Hsu, PI | 1 |
| Lo, GH | 1 |
| Lo, CC | 1 |
| Lin, CK | 1 |
| Shie, CB | 1 |
| Peng, NJ | 1 |
| Tseng, HH | 1 |
| Jou, HS | 1 |
| Tsai, PM | 1 |
| Chen, A | 1 |
| Chen, JL | 1 |
| Lai, KH | 1 |
| Kubota, K | 2 |
| Shimizu, N | 2 |
| Nozaki, K | 1 |
| Takeshita, Y | 1 |
| Ueda, T | 1 |
| Imamura, K | 1 |
| Hiki, N | 1 |
| Yamaguchi, H | 1 |
| Shimoyama, S | 1 |
| MaFune, K | 1 |
| Kaminishi, M | 2 |
| Oka, M | 1 |
| Ichinose, M | 1 |
| Fujishiro, M | 1 |
| Omata, M | 1 |
| Kamada, T | 1 |
| Haruma, K | 1 |
| Miyoshi, E | 1 |
| Mihara, M | 1 |
| Kitadai, Y | 1 |
| Yoshihara, M | 1 |
| Sumii, K | 1 |
| Kajiyama, G | 1 |
| Tahara, K | 1 |
| Mukai, T | 1 |
| Kawamura, Y | 1 |
| Hattori, N | 1 |
| Adachi, K | 1 |
| Suetsugu, H | 1 |
| Moriyama, N | 1 |
| Kazumori, H | 1 |
| Kawamura, A | 1 |
| Fujishiro, H | 1 |
| Sato, H | 1 |
| Okuyama, T | 1 |
| Ishihara, S | 1 |
| Watanabe, M | 1 |
| Kinoshita, Y | 1 |
1 review available for cetraxate and Infections, Helicobacter
| Article | Year |
|---|---|
[Eradication therapy for the remnant stomach infected with Helicobacter pylori ].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; En | 2005 |
5 trials available for cetraxate and Infections, Helicobacter
| Article | Year |
|---|---|
Comparison of cetraxate-based and pantoprazole-based triple therapies in the treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer | 2004 |
Efficacy of triple therapy plus cetraxate for the Helicobacter pylori eradication in partial gastrectomy patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Infective Agents; Anti-Ulcer Agents; Drug | 2005 |
[Cetraxate hydrochloride (Neuer) induces the effectiveness of new triple therapy in H. pylori eradication].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clar | 2005 |
Cetraxate, a mucosal protective agent, combined with omeprazole, amoxycillin, and clarithromycin increases the eradication rate of helicobacter pylori in smokers.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Met | 2000 |
Influence of Helicobacter pylori infection and cetraxate on gastric mucosal blood flow during healing of endoscopic mucosal resection-induced ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Anti-Ulcer Agents; Female; Gastric | 2001 |